Dr. Amelia A. Langston, MD

Dr. Langston practices at Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University.

Dr. Langston's NPI, 1346357019, was assigned on August 25, 2006. Dr. Langston graduated from Washington University School of Medicine in 1984. Dr. Langston holds Georgia license 44952.

Dr. Langston's primary practice is Emory University Hospital Midtown, at 550 Peachtree Street, NE, Atlanta, GA 30308 in Fulton County. The practice phone is (404) 686-2450.

Dr. Langston's primary practice is Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University. Dr. Langston is also affiliated with Emory University Hospital. The medical group on file is Emory Clinic. Dmand AI also links Dr. Langston to 1 more hospital, 1 clinical lab, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Langston practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Langston's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Langston is licensed in Georgia.

CMS data shows 341 Medicare services from Dr. Langston across 6 procedure codes in 2024, for 141 Medicare patients. Medicare paid $25,291 for them.

CMS counts 141 Medicare patients who saw Dr. Langston in 2024. The largest group is 65 to 74, with 79 patients. 69% of them have high cholesterol, and 65% have high blood pressure. 9% are also on Medicaid. Their average risk score is 2.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Langston's median patient age at 69, with 48% women.

In 2024, Dr. Langston wrote 864 Medicare Part D claims for 124 patients. 57% of them were for generic drugs. CMS names the drug for 612 of them, across 23 drugs with 11 or more claims each, at $4,872,064 in total drug cost. In 2023, CMS named 871 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Langston for performance year 2024, reported through an alternative payment model (APM). Dr. Langston accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Langston as offering telehealth.

Dmand AI links 95 papers to Dr. Langston, published from 2010 to 2025. 2017 was the busiest year, with 7. The most frequent topics are Hematopoietic Stem Cell Transplantation, Graft vs Host Disease and Transplantation Conditioning. Dr. Langston has published most often in Bone Marrow Transplant. Dr. Langston's most frequent co-authors are Sagar Lonial, MD, Leonard T. Heffner, MD and Edmund K. Waller, MD.

Dmand AI links Dr. Langston to 8 clinical trials, 4 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Anemia, Sickle Cell, Graft vs Host Disease and Anemia, Hemolytic, Congenital. Boston Children's Hospital sponsors the most, 2.

CMS Open Payments shows 33 general payments to Dr. Langston from 9 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 53% of the total. Pfizer Inc. paid the most, $2,637. It also lists 8 research payments totaling $21,979 in 2019.

Dr. Langston graduated from Washington University School of Medicine in 1984.